160 related articles for article (PubMed ID: 24989671)
1. Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression.
Wright PW; Li H; Huehn A; O'Connor GM; Cooley S; Miller JS; Anderson SK
Genes Immun; 2014 Oct; 15(7):440-8. PubMed ID: 24989671
[TBL] [Abstract][Full Text] [Related]
2. The KIR2DL1 intermediate upstream element participates in gene activation.
Wright PW; Li H; Rahman MA; Anderson EM; Karwan M; Carrell J; Anderson SK
Immunogenetics; 2023 Dec; 75(6):495-506. PubMed ID: 37801092
[TBL] [Abstract][Full Text] [Related]
3. [Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].
Gao XN; Lin J; Wang LL; Gao L; Jin HJ; Sun JF; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):656-60. PubMed ID: 19549382
[TBL] [Abstract][Full Text] [Related]
4. Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population.
Hilton HG; Norman PJ; Nemat-Gorgani N; Goyos A; Hollenbach JA; Henn BM; Gignoux CR; Guethlein LA; Parham P
PLoS Genet; 2015 Aug; 11(8):e1005439. PubMed ID: 26292085
[TBL] [Abstract][Full Text] [Related]
5. Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.
Falco M; Meazza R; Alicata C; Canevali P; Muntasell A; Bottino C; Moretta L; Pende D; Lopez-Botet M
HLA; 2022 Aug; 100(2):107-118. PubMed ID: 35411634
[TBL] [Abstract][Full Text] [Related]
6. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
[TBL] [Abstract][Full Text] [Related]
7. Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes.
Li H; Wright PW; McCullen M; Anderson SK
Genes Immun; 2016; 17(1):66-74. PubMed ID: 26656451
[TBL] [Abstract][Full Text] [Related]
8. Single Nucleotide Polymorphism in
Vargas LB; Dourado RM; Amorim LM; Ho B; Calonga-Solís V; Issler HC; Marin WM; Beltrame MH; Petzl-Erler ML; Hollenbach JA; Augusto DG
Front Immunol; 2020; 11():1881. PubMed ID: 32983108
[TBL] [Abstract][Full Text] [Related]
9. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
[TBL] [Abstract][Full Text] [Related]
10. An Improved Method With High Specificity for KIR2DL1 Functional Allele Typing.
Bari R; Schell S; Tuggle M; Leung W
Lab Med; 2015; 46(3):207-13. PubMed ID: 26199260
[TBL] [Abstract][Full Text] [Related]
11. Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma.
Dutta A; Saikia N; Phookan J; Baruah MN; Baruah S
Immunogenetics; 2014 Aug; 66(7-8):439-48. PubMed ID: 24818561
[TBL] [Abstract][Full Text] [Related]
12. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
Front Immunol; 2019; 10():734. PubMed ID: 31024561
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
14. Identification of distal KIR promoters and transcripts.
Stulberg MJ; Wright PW; Dang H; Hanson RJ; Miller JS; Anderson SK
Genes Immun; 2007 Mar; 8(2):124-30. PubMed ID: 17159886
[TBL] [Abstract][Full Text] [Related]
15. Characterization of KIR
Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
[TBL] [Abstract][Full Text] [Related]
16. Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells.
Fourmentraux-Neves E; Jalil A; Da Rocha S; Pichon C; Chouaib S; Bismuth G; Caignard A
Blood; 2008 Sep; 112(6):2381-9. PubMed ID: 18574028
[TBL] [Abstract][Full Text] [Related]
17. Identification of bidirectional promoters in the human KIR genes.
Davies GE; Locke SM; Wright PW; Li H; Hanson RJ; Miller JS; Anderson SK
Genes Immun; 2007 Apr; 8(3):245-53. PubMed ID: 17315044
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.
Cichocki F; Hanson RJ; Lenvik T; Pitt M; McCullar V; Li H; Anderson SK; Miller JS
Blood; 2009 Apr; 113(14):3245-53. PubMed ID: 18987359
[TBL] [Abstract][Full Text] [Related]
19. KIR Polymorphism Modulates the Size of the Adaptive NK Cell Pool in Human Cytomegalovirus-Infected Individuals.
Manser AR; Scherenschlich N; Thöns C; Hengel H; Timm J; Uhrberg M
J Immunol; 2019 Oct; 203(8):2301-2309. PubMed ID: 31519864
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
